Jack Lief

This profile gathers the share dealings of Jack Lief in Arena Pharmaceuticals Inc. In total, 20 filings cover trades dated from 30 December 2005 to 3 March 2015.

No open-market purchase appears, only 2 sales worth €1.5M. Outside the open market, there are 4 share grants and 3 option exercises.

The newest entry dates from 4 March 2015: an option exercise of €167k, in Arena Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.